1. Home
  2. STG vs ENTX Comparison

STG vs ENTX Comparison

Compare STG & ENTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • STG
  • ENTX
  • Stock Information
  • Founded
  • STG 2003
  • ENTX 2010
  • Country
  • STG China
  • ENTX Israel
  • Employees
  • STG N/A
  • ENTX N/A
  • Industry
  • STG Other Consumer Services
  • ENTX Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • STG Real Estate
  • ENTX Health Care
  • Exchange
  • STG Nasdaq
  • ENTX Nasdaq
  • Market Cap
  • STG 91.6M
  • ENTX 90.2M
  • IPO Year
  • STG 2018
  • ENTX 2018
  • Fundamental
  • Price
  • STG $6.82
  • ENTX $2.51
  • Analyst Decision
  • STG
  • ENTX Strong Buy
  • Analyst Count
  • STG 0
  • ENTX 1
  • Target Price
  • STG N/A
  • ENTX $10.00
  • AVG Volume (30 Days)
  • STG 10.0K
  • ENTX 84.8K
  • Earning Date
  • STG 03-21-2025
  • ENTX 03-07-2025
  • Dividend Yield
  • STG N/A
  • ENTX N/A
  • EPS Growth
  • STG N/A
  • ENTX N/A
  • EPS
  • STG 4.57
  • ENTX N/A
  • Revenue
  • STG $292,030,936.00
  • ENTX $99,000.00
  • Revenue This Year
  • STG N/A
  • ENTX N/A
  • Revenue Next Year
  • STG N/A
  • ENTX N/A
  • P/E Ratio
  • STG $1.49
  • ENTX N/A
  • Revenue Growth
  • STG N/A
  • ENTX 607.14
  • 52 Week Low
  • STG $4.25
  • ENTX $0.82
  • 52 Week High
  • STG $12.55
  • ENTX $3.35
  • Technical
  • Relative Strength Index (RSI)
  • STG 57.89
  • ENTX 54.94
  • Support Level
  • STG $6.51
  • ENTX $2.00
  • Resistance Level
  • STG $6.78
  • ENTX $2.62
  • Average True Range (ATR)
  • STG 0.26
  • ENTX 0.19
  • MACD
  • STG 0.04
  • ENTX -0.00
  • Stochastic Oscillator
  • STG 80.49
  • ENTX 69.35

About STG Sunlands Technology Group

Sunlands Technology Group is a provider of online post-secondary and professional education services in China. The company offers various degree- and diploma-oriented post-secondary courses through its online platforms. In addition, it provides online professional courses and educational content to help students prepare for professional certification exams and attain professional skills. The Group has one operating segment, which is the provision of online education services.

About ENTX Entera Bio Ltd.

Entera Bio Ltd is a clinical-stage biopharmaceutical company engaged in the development of orally delivered macromolecule therapeutics, including peptides and therapeutic proteins. The company focuses on underserved, chronic medical conditions where oral administration of a mini tablet peptide or peptide replacement therapy has the potential to significantly shift a treatment paradigm. Its product candidates are; EB613 for the treatment of osteoporosis and EB612 for the treatment of hypoparathyroidism are first-in-class mini tablet formulations of synthetic human PTH (1-34) (teriparatide), designed to have differing pharmacokinetic, or PK, profiles.

Share on Social Networks: